A subgroup analysis finds adding Control-IQ+ automated insulin delivery to GLP-1 agonist therapy lowers HbA1c and improves time in range without weight gain in insulin-treated type 2 diabetes. PICO summary and commentary.
Browsing: Diabetes Technology & Monitoring
Continuous glucose monitoring, insulin pumps, closed-loop systems, and digital tools in diabetes care.
A small pilot RCT finds early automated insulin delivery is feasible and well accepted in underresourced youth with new type 1 diabetes, with a non-significant trend toward better glucose control. PICO summary and commentary.
A small RCT finds a digital-twin decision-support system with a simulation-assisted bolus calculator improves time in range and reduces hypoglycaemia in type 1 diabetes. PICO summary and commentary.
Clinical Context Gestational diabetes mellitus (GDM) affects 6-9% of pregnancies globally and is associated with significant maternal and fetal complications.…
A 3-month MOBILE analysis finds CGM lowers HbA1c more than fingerstick monitoring and reduces hypoglycaemia in basal-insulin-treated type 2 diabetes, with benefits within a week. PICO summary and commentary.
A crossover trial finds two extended-bolus algorithms both control post-meal glucose in adolescent type 1 diabetes; the simpler Sieradzki method trends better but not significantly. PICO summary and commentary.
A small pilot finds a fully closed-loop insulin-pramlintide system without carb counting achieves time in range similar to carb-counted control, with a non-significant hypoglycaemia signal. PICO summary and commentary.
Summary: In adults with type 1 diabetes requiring insulin therapy, a fully closed-loop system combining automated insulin and pramlintide delivery…
Summary: In adults receiving primary care with BMI ≥27 kg/m² and at least one cardiovascular risk factor, enrolled via electronic…
Summary: In adults with type 2 diabetes in resource-limited, peri-urban and rural primary health center (PHC) areas in India, ASHA-led…